Can higher reverse T3 explain fatigue, constipation, and cognitive slowing despite normal TSH and free T4?

Clinical evidence

• Symptom Persistence Despite Normal Labs: High-quality clinical evidence demonstrates that a significant subset of patients experience persistent hypothyroid symptoms—such as fatigue, constipation, and cognitive slowing—even when standard serum markers like thyroid-stimulating hormone (TSH) and free thyroxine (FT4) fall within reference ranges.
• Tissue-Specific Euthyroidism: Standard serum panels do not reliably capture tissue-level thyroid hormone status. Intracellular thyroid signaling can be compromised in peripheral tissues while maintaining a biochemically "normal" hypothalamic-pituitary-thyroid (HPT) axis.

Mechanistic explanations

• Deiodinase Dynamics: The generation of reverse T3 (rT3) is driven by Type 3 deiodinase (D3), the primary inactivating enzyme that converts T4 into rT3, and T3 into active diiodothyronine (T2).
• Marker vs. Mediator: While elevated rT3 is associated with reduced thyroid hormone action, rT3 itself does not act as a direct competitive antagonist at the thyroid hormone nuclear receptors (TRα and TRβ) under physiological conditions.
• Reduced Intracellular Signaling: Elevated rT3 is a metabolic biomarker of increased D3 activity and/or decreased Type 2 deiodinase (D2) activity (which converts T4 to active T3). The resulting shift reduces cellular T3 availability, leading to diminished thyroid hormone receptor binding, altered gene transcription, and subsequent tissue-level hypothyroidism.

Bottom line

• Elevated reverse T3 is a valid biomarker of altered thyroid hormone metabolism and reduced intracellular T3 availability. While it does not directly block thyroid receptors to cause fatigue, constipation, or cognitive slowing, it reflects a state of impaired tissue-level thyroid action that can exist despite normal TSH and free T4 levels.